Jun 14, 2022 / 09:00PM GMT
Karen Hunady - Athersys, Inc. - Director of Corporate Communications & IR
Hello, everyone, and welcome to today's panel discussion. My name is Karen Hunady, and I'm the Director of Corporate Communications and Investor Relations at Athersys. And I'd like to thank you for joining us today to learn more about the TREASURE data. The TREASURE study was conducted by Healios, our partner in Japan, and it was a randomized double-blinded, placebo-controlled study evaluating MultiStem administration for the treatment of ischemic stroke.
We have put together an expert panel of key opinion leaders in the field of neurology to discuss their own perspective on the TREASURE data. I do want to thank each one of them for taking the time out of their busy clinical schedules to be here with us today. Dr. Robert Willie Mays, our Vice President of Regenerative Medicine and Head of Neuroscience programs here at Athersys, will be moderating the event today. He's going to be taking questions from all of you on this webinar, and directing those questions to the panelists. We will be answering all the questions
Athersys Inc KOLPanel Event About TREASURE Data Discussion Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers